COMP <GO>
CHE vs JNJ // 10Y YIELD & FRED MACRO BETA
Chemed Corp (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CHE 5
— JNJ 7
■ METRIC PARITY
LAST: $534.72 (-1.33%) • MKT CAP: $7.08B
macro-sensitivity
1.08
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CHE VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CHE | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.50% | 67.90% | -35.40 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.40% | 25.50% | -2.10 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.5x | 18.5x | 0.00 | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.60% | 2.97% | +1.63 | CHE | /fcf-yield <GO> |
| Operating Margin | 13.40% | 34.70% | -21.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 28.50% | -28.50 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 65.30% | 6.00% | +59.30 | CHE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.45% | 0.00% | +0.45 | CHE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.68 | 5.59 | +7.09 | CHE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.20% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.8 | 60.4 | +1.44 | CHE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 1.08 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 23.0x | +117.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.08B | $662.49B | -$655.41B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CHE REV | JNJ REV | CHE GROSS % | JNJ GROSS % | CHE FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $94.19B | 32.5% | 67.9% | $325.5M | $19.70B |
| FY 2024 | $1.53B | $88.82B | -3.0% | 69.1% | $368.0M | $19.84B |
| FY 2023 | $1.32B | $85.16B | 44.0% | 44.0% | $271.1M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CHE // BETA 1.08
JNJ // BETA 1.08